MedTrace Logo

Plasma-based Colorectal Cancer Screening Research & Development

NCT04027790 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 354

Last updated 2021-02-02

No results posted yet for this study

Summary

The objective of this Clinical Sample Collection Study is to develop a biobank of appropriately collected plasma samples from colorectal cancer patients (i.e. AJCC/UICC stages 0, I, II, III) prior to therapeutic intervention, and from people reporting for colorectal cancer screening by colonoscopy, prior to bowel preparation.

Conditions

  • Colo-rectal Cancer

Interventions

DIAGNOSTIC_TEST

Epi proColon

Analysis of DNA methylation status for Septin9 and additional biomarkers

Sponsors & Collaborators

  • Epigenomics, Inc

    lead INDUSTRY

Principal Investigators

  • Theo deVos, PhD · Epigenomics, Inc

Eligibility

Min Age
45 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-03
Primary Completion
2020-03-31
Completion
2020-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04027790 on ClinicalTrials.gov